Your session is about to expire
← Back to Search
Sustained Acoustic Device with 2.5% Diclofenac Patch for Osteoarthritis
Study Summary
This trial will compare two methods of treating symptoms of knee osteoarthritis: Sustained Acoustic Medicine (SAM) vs a topical pain relief gel. Pain and function scores will be measured to determine which method is more effective.
- Osteoarthritis of the Knee
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are individuals over the age of fifty-five eligible to participate in this experiment?
"This clinical trial seeks patients aged 35 to 80. Participants younger than 18 have access to 38 other trials, and those older than 65 can choose from 656 studies."
Is enrollment for this trial currently open?
"Affirmative. Per the details on clinicaltrials.gov, recruitment for this investigation is underway; it was launched on February 14th 2022 and subsequently updated the same day. The research team seeks 90 participants from 1 medical centre."
What criteria must individuals meet to be considered for enrollment in this trial?
"This medical study seeks to enrol 90 patients suffering from arthrosis aged between 35 and 80. Prospective applicants must fulfil the following criteria: Have physician-diagnosed mild or moderate knee arthritis (OARSI atlas grades 1-2), Meet American College of Rheumatology's clinical and radiological diagnostic standards for knee OA, Report a frequent pain score between 3-7 during the week preceding entry, Demonstrate how their knee agony impairs quality of life, Be willing not to use any cream, gel or topical solution other than that provided at commencement of trial., Be deemed fit by a doctor to participate in this research"
Has the Sustained Acoustic Device with 2.5% Diclofenac Patch been given regulatory clearance by the FDA?
"The safety of Sustained Acoustic Device with 2.5% Diclofenac Patch was rated a 1 according to our team's assessment at Power, as this is only Phase 1 trial and there are limited data verifying both its efficacy and security."
What is the current enrollment level of this clinical experiment?
"Affirmative. The details uploaded to clinicaltrials.gov demonstrate that this medical trial, which was launched on February 14th 2022, is presently recruiting individuals for participation. 90 participants are sought from 1 distinct site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger